Inventor · disambiguated record
Yue Pan
Also filed as: PAN YUE
15 granted patents·12 pending applications·94 citations·filing 2003–2025
92Inventor score
Files withNOVARTIS AG8RELAY THERAPEUTICS INC3ABRAMS TINYA2ACACIA COMMUNICATIONS INC2ANTONIOS-MCCREA WILLIAM R2
Top patents by PatentIndex Score
27 records- 0196US6794413B1Compounds and related methods for inhibition of γ-aminobutyric acid aminotransferaseUNIV NORTHWESTERN·Filed 2003·Granted Sep 21, 2004·45 cites·35 claims
- 0289US10709712B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Jul 14, 2020·3 cites·7 claims
- 0388US7381748B1Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferaseUNIV NORTHWESTERN·Filed 2004·Granted Jun 3, 2008·15 cites·17 claims
- 0484US10245267B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Apr 2, 2019·3 cites·4 claims
- 0584US9694016B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jul 4, 2017·5 cites·8 claims
- 0683US10188649B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 29, 2019·3 cites·4 claims
- 0781US8415381B2Heteroaryl compounds and their usesBARSANTI PAUL A·Filed 2010·Granted Apr 9, 2013·7 cites·12 claims
- 0880US9763937B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2015·Granted Sep 19, 2017·3 cites·4 claims
- 0980US9242996B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2014·Granted Jan 26, 2016·5 cites·27 claims
- 1079US8778951B2Heteroaryl compounds and their usesNOVARTIS AG·Filed 2013·Granted Jul 15, 2014·4 cites·8 claims
- 1171US11394490B1Q marginACACIA COMMUNICATIONS INC·Filed 2019·Granted Jul 19, 2022·1 cites·16 claims
- 1268US12015481B1Q marginACACIA COMMUNICATIONS INC·Filed 2022·Granted Jun 18, 2024·0 cites·20 claims
- 1367US10660888B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2018·Granted May 26, 2020·0 cites·6 claims
- 1466US2025313524A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1556US2024208953A1"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"NOVARTIS AG·Filed 2022·Application pending·0 cites
- 1655US8546434B2Triazole compounds as KSP inhibitorsABRAMS TINYA·Filed 2011·Granted Oct 1, 2013·0 cites·22 claims
- 1755US2014056880A1Triazole compounds as ksp inhibitorsABRAMS TINYA·Filed 2013·Application pending·0 cites
- 1855US2025382670A1Novel compositions and methods for cell-free dna detectionJIANGSU CODE BIOMEDICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 1954US2024199576A1Novel cyclopenta[c]pyrrol negative allosteric modulators of nr2bNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2054US2025084048A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2154US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2254US2014288076A1Heteroaryl compounds and their usesBARSANTI PAUL A·Filed 2014·Application pending·0 cites
- 2348US2025319201A1Mutant of adeno-associated virus and use thereofPACKGENE BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 2446US2025325696A1Mutant of adeno-associated virus and use thereofPACKGENE BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 2545US10444237B2Anti-pancreatic cancer monoclonal antibody and use thereofNANJING MARKERLINE BIOMEDICAL TECH CO LTD·Filed 2016·Granted Oct 15, 2019·0 cites·7 claims
- 2639US2013303507A1Substituted hetero-biaryl compounds and their usesANTONIOS-MCCREA WILLIAM R·Filed 2012·Application pending·0 cites
- 2738US2013324530A13-(aminoaryl)-pyridine compoundsANTONIOS-MCCREA WILLIAM R·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yue Pan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →